Cell and gene therapy (CGT) manufacturers can struggle to move from lab-scale to clinical-scale production. Automation can help but, to make a success of the transition, developers must be willing to ...

Automation and sector-wide collaboration will be critical as developers try to move beyond the production challenges that slow growth of the cell and gene therapy sector. So says Julie G. Allickson, ...

Discovery of efficient anti-cancer drugs and drug combinations is essential for therapy success. Therefore, it is crucial that new methods for efficient drug efficacy testing are developed to support ...

Automated tissue culture systems, like the SelecT automated mammalian cell culture system shown here, provide a level of plate-to-plate uniformity that can be difficult to achieve manually. And ...

Cell therapy manufacturing has long been constrained by manual bottlenecks - steps that are labor-intensive, variable, and difficult to scale. Robotic automation is increasingly becoming key to ...

SOUTH SAN FRANCISCO, Calif., Sept. 11, 2023 /PRNewswire/ -- Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy ...

Today, the majority of cell biology operations are carried out manually, even though the core steps are highly reproducible. Staff are expected to conduct repetitive tasks for hours each day, and ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, ...

To start off, could you introduce yourselves and Unicorn Biotechnologies? Jack: I’m Jack, one of the co-founders of Unicorn Biotechnologies. My background is in chemistry, and I’ve worked across ...

Engineers have created new technology that can move cells without touching them, enabling critical tasks that currently require large pieces of lab equipment to be carried out on a benchtop device.